BIOGEN Optimistic for Rapid and Broad Patient Access Following Invitation to Submit SPINRAZA® (nusinersen)▼ to National Institute for Health and Care Excellence (NICE) for Single Technology Appraisal (STA)

MAIDENHEAD, England, January 22, 2018 /PRNewswire/ -- Managed Access Agreement to be developed in parallel to urgently provide effective new treatment to patients in England The National Institute for Health and Care Excellence (NICE) has formally invited Biogen to submit...

from PR Newswire: //http://ift.tt/2mZsDix